GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Price-to-Free-Cash-Flow

3SBio (TRSBF) Price-to-Free-Cash-Flow : 10.13 (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is 3SBio Price-to-Free-Cash-Flow?

As of today (2024-05-11), 3SBio's share price is $0.80. 3SBio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08. Hence, 3SBio's Price-to-Free-Cash-Flow Ratio for today is 10.13.

The historical rank and industry rank for 3SBio's Price-to-Free-Cash-Flow or its related term are showing as below:

TRSBF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.03   Med: 40.15   Max: 70.51
Current: 10.92

During the past 10 years, 3SBio's highest Price-to-Free-Cash-Flow Ratio was 70.51. The lowest was 8.03. And the median was 40.15.

TRSBF's Price-to-Free-Cash-Flow is ranked better than
84.55% of 220 companies
in the Biotechnology industry
Industry Median: 31.585 vs TRSBF: 10.92

3SBio's Free Cash Flow per Share for the six months ended in Dec. 2023 was $0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.08.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of 3SBio was 26.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 58.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 9.60% per year.

During the past 10 years, 3SBio's highest 3-Year average Free Cash Flow per Share Growth Rate was 58.20% per year. The lowest was -25.10% per year. And the median was 16.50% per year.


3SBio Price-to-Free-Cash-Flow Historical Data

The historical data trend for 3SBio's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Price-to-Free-Cash-Flow Chart

3SBio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.45 45.58 34.03 16.97 12.17

3SBio Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.03 - 16.97 - 12.17

Competitive Comparison of 3SBio's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, 3SBio's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 3SBio's Price-to-Free-Cash-Flow falls into.



3SBio Price-to-Free-Cash-Flow Calculation

3SBio's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.80/0.079
=10.13

3SBio's Share Price of today is $0.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3SBio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

3SBio  (OTCPK:TRSBF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


3SBio Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of 3SBio's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio (TRSBF) Business Description

Traded in Other Exchanges
Address
No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027
3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines